Modelling Neuroinflammation In Vitro: A Tool to Test the Potential Neuroprotective Effect of Anti-Inflammatory Agents

PLoS ONE

Volumn 7, Issue 9, 2012, Pages

  Gresa Arribas, Núria ^a   Viéitez, Cristina ^a   Dentesano, Guido ^a   Serratosa, Joan ^a   Saura, Josep ^b   Solà, Carme ^a  

^a INSTITUT D INVESTIGACIONS BIOMÈDIQUES AUGUST PI I SUNYER IDIBAPS   (Spain)

^b UNIVERSITY OF BARCELONA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFLAMMATORY AGENT; CYCLOOXYGENASE 2; GAMMA INTERFERON; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 10; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; N [3 (AMINOMETHYL)BENZYL]ACETAMIDINE; NITRIC OXIDE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ARTICLE; COCULTURE; CONTROLLED STUDY; CYTOKINE RELEASE; DRUG EFFECT; IN VITRO STUDY; MICROGLIA; MOUSE; NERVE CELL CULTURE; NERVOUS SYSTEM INFLAMMATION; NEUROPROTECTION; NEUROTOXICITY; NEWBORN; NONHUMAN; PROTEIN EXPRESSION;

ANIMALS; ANTI-INFLAMMATORY AGENTS; CELL LINE; COCULTURE TECHNIQUES; CYCLOOXYGENASE 2; GENE EXPRESSION; IMINES; INFLAMMATION; INTERFERON-GAMMA; INTERLEUKIN-10; INTERLEUKIN-6; LIPOPOLYSACCHARIDES; MICE; MICROGLIA; MODELS, BIOLOGICAL; NEURONS; NEUROPROTECTIVE AGENTS; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE II; PRIMARY CELL CULTURE;

EID: 84866705875     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0045227     Document Type: Article

References (43)

1. Glass CK, Saijo K, Winner B, Marchetto MC, Cage FH, (2010) Mechanisms underlying inflammation in neurodegeneration. Cell 140: 918-934.
2. Perry VH, Nicoll JAR, Holmes C, (2010) Microglia in neurodegenerative disease. Nat Rev 6: 193-201.
3. Carson MJ, Crane J, Xie AX, (2008) Modeling CNS microglia: the quest to identify predictive models. Drug Discov Today Dis Models 5: 19-25.
4. Lee H, Kim YO, Kim H, Kim SY, Noh HS, et al. (2003) Flavonoid wogonin from medicinal herb is neuroprotective by inhibiting inflammatory activation of microglia. FASEB J 17: 1943-1944.
5. Qian L, Xu Z, Zhang W, Wilson B, Hong J-S, et al. (2007) Simomenine, a natural dextrorotatory morphinan analog, is anti-inflammatory and neuroprotective through inhibition of microglial NADPH oxidase. J Neuroinflamm 4: 23-36.
6. Pan XD, Chen XC, Zhu YG, Zhang J, Huang TW, et al. (2008) Neuroprotective role of tripchlorolide on inflammatory neurotoxicity induced by lipopolysaccharide-activated microglia. Biochem Pharmacol 76: 362-372.
7. Zheng LT, Ryu GM, Kwon bM, Lee WH, Suk K, (2008) Anti-inflammatory effects of cathecols in lipopolysaccharide-stimulated microglia cells: inhibition of microglia neurotoxicity. Eur J Pharmacol 588: 106-113.
8. Li Y, Hu X, Liu Y, Bao Y, An L, (2009) Nimodipine protects dopaminergic neurons against inflammation-mediated degeneration through inhibition of microglial activation. Neuropharmacology 56: 580-589.
9. Ransohoff RM, Cardona AE, (2010) The myeloid cells of the central nervous system parenchyma. Nature 468: 253-262.
10. Lawson LJ, Perry VH, Dri P, Gordon S, (1990) Heterogeneity in the distribution and morphology of microglia in the normal adult mouse brain. Neuroscience 39: 151-170.
11. Kim W-G, Mohney RP, Wilson B, Jeohn G-H, Liu B, et al. (2000) Regional difference in susceptibility in lipopolysaccharide-induced neurotoxicity in the rat brain: role of microglia. J Neurosci 20: 6309-6316.
12. Gibbons HM, Dragunov M, (2006) Microglia induce neural cell death via a proximity-dependent mechanism involving nitric oxide. Brain Res 1084: 1-15.
13. Jin S, Kawanokuchi J, Mizuno T, Wang J, Sonobe Y, et al. (2007) Interferon-β is neuroprotective against the toxicity induced by activated microglia. Brain Res 1179: 140-146.
14. Couturier J, Paccalin M, Morel M, Terro F, Milin S, et al. (2011) Prevention of the β-amyloid peptide-induced inflammatory process by inhibition of double-stranded RNA-dependent protein kinase in primary murine mixed co-cultures. J Neuroinflam 8: 72-89.
15. Gorlovoy P, Larionov S, Pham TTH, Neumann H, (2009) Accumulation of tau induced in neuritis by microglial proinflammatory mediators. FASEB J 23: 2502-2513.
16. Gray E, Ginty M, Kemp K, Scolding N, Wilkins A, (2011) Peroxisome proliferator-activated receptor-α agonists protect cortical neurons from inflammatory mediators and improve peroxisomal function. Eur J Neurosci 33: 1421-1432.
17. Blasi E, Barluzzi R, Bocchini V, Mazzolla R, Bistoni F, (1990) Immortalization of murine microglial cells by a v-raf/v-myc carrying retrovirus. J Neuroimmunol 27: 229-237.
18. Saura J, Tusell JM, Serratosa J, (2003) High-yield isolation of murine microglia by mild tripsinization. Glia 44: 183-189.
19. Frandsen A, Schousboe A, (1990) Development of excitatory aminoacid induced cytotoxicity in cultured neurons. Int J Dev Neurosci 8: 209-216.
20. Ejarque-Ortiz A, Gresa-Arribas N, Straccia M, Mancera P, Solà C, et al. (2010) CCAAT/enhancer binding protein delta in microglial activation. J Neurosci Res 88: 1113-1123.
21. Gresa-Arribas N, Serratosa J, Saura J, Solà C, (2010) Inhibition of CCAAT/enhancer binding protein δ expression by chrysin in microglial cells results in anti-inflammatory and neuroprotective effects. J Neurochem 115: 526-536.
22. Chang RCC, Hudson PM, Wilson BC, Liu B, Abel H, et al. (2000) High concentrations of extracellular potassium enhance bacterial endotoxin lipopolysaccharide-induced neurotoxicity in glia-neuron mixed cultures. Neuroscience 97: 757-764.
23. Henn A, Lund S, Hedtjärn M, Schrattenholz A, Pörzgen P, et al. (2009) The suitability of BV2 cells as alternative model system for primary microglia cultures or for animal experiments examining brain inflammation. ALTEX 26: 83-94.
24. Horvath R, Nutile-McMenemy N, Alkaitis MS, DeLeo JA, (2008) Differential migration, LPS-induced cytokine, chemokine, and NO expression in immortalized BV-2 and HAPI cell lines and primary microglial cultures. J Neurochem 107: 557-569.
25. de Jong EK, de Hass AH, Nieske B, van Weering HRJ, Hensens M, et al. (2008) Expression of CXCL4 in microglia in vitro and in vivo and its possible signalling through CXCR3. J Neurochem 105: 1726-1736.
26. Ledeboer A, Brevé JJP, Poole S, Tilders FJH, Van Dam, (2000) A-M (2000) Interleukin-10, interleukin-4, and transforming growth factor-β differentially regulate lipopolysaccharide-induced production of pro-inflammatory cytokines and nitric oxide in co-cultures of rat astroglial and microglial cells. Glia 30: 134-142.
27. Molina-Holgado F, Grencis R, Rothwell NJ, (2001) Actions of exogenous and endogenous IL-10 on glial responses to bacterial LPS/cytokines. Glia 33: 97-106.
28. Szczepanik AM, Funes S, Petko W, Ringheim GE, (2001) IL-4, IL-10 and IL-13 modulate Aβ(1-42)-induced cytokine and chemokine production in primary murine microglia and a human monocyte cell line. J Neuroimmunol 113: 49-62.
29. Lieb K, Engels S, Fiebich BL, (2003) Inhibition of LPS-induced iNOS and NO synthesis in primary rat microglial cells. Neurochem Int 42: 131-137.
30. Minguetti L, Polazzi E, Nicolini A, Levi G, (1998) Opposite regulation of prostaglandin E2 synthesis by transforming growth factor-β1 and interleukin 10 in activated microglial cultures. J Neuroimmunol 82: 31-39.
31. Qian L, Block ML, Wei S-J, Lin C-F, Reece J, et al. (2006) Interleukin-10 protects lipopolysaccharide-induced neurotoxicity in primary midbrain cultures by inhibiting the function of NADPH oxidase. J Pharmacol Exp Ther 319: 44-52.
32. Arimoto T, Choi DY, Lu X, Liu M, Nguyen XV, et al. (2006) Interleukin-10 protects against inflammation-mediated degeneration of dopaminergic neurons in substantia nigra. Neurobiol Aging 28: 894-906.
33. Zhou Z, Peng X, Insolera R, Fink DJ, Mata M, (2009a) Interleukin-10 provides direct trophic support to neurons. J Neurochem 110: 1617-1627.
34. Sharma S, Yang B, Grotta JC, Aronowski J, Savitz SI, (2011) IL-10 directly protects cortical neurons by activating PI-3 kinase and STAT-3 pathways. Brain Res 1373: 189-194.
35. Zhou Z, Peng X, Insolera R, Fink DJ, Mata M, (2009b) Interleukin-10 promotes neuronal survival following spinal cord injury. Exp Neurol 220: 183-190.
36. Brewer KL, Bethea JR, Yezierski RP, (1999) Neuroprotective effects of IL-10 following excitotoxic spinal cord injury. Exp Neurol 159: 484-493.
37. Mesples B, Plaisant F, Gressens P, (2003) Effect of interleukin-10 on neonatal excitotoxic brain lesions in mice. Dev Brain Res 141: 25-32.
38. Gonzalez P, Peluffo H, Acarin L, Villaverde A, Gonzalez B, et al. (2012) Interleukin-10 overexpression does not synergize with the neuroprotective action of RGD-containing vectors after postnatal brain excitotoxicity but modulates the main inflammatory cell responses. J Neurosci Res 90: 143-159.
39. Stewart VC, Heales SJ, (2003) Nitric oxide-induced mitochondrial dysfunction: implications for neurodegeneration. Free Radic Biol Med 34: 287-303.
40. Moncada S, Bolaños JP, (2006) Nitric oxide, cell bioenergetics and neurodegeneration. J Neurochem 97: 1676-89.
41. Bal-Price A, Matthias A, Brown GC, (2002) Stimulation of the NADPH oxidase in activated rat microglia removes nitric oxide but induces peroxynitrite production. J Neurochem 80: 73-80.
42. Brown GC, Bal-Price A, (2003) Inflammatory neurodegeneration mediated by nitric oxide, glutamate, and mitochondria. Mol Neurobiol 27: 325-355.
43. Zhang L, Dawson VL, Dawson TM, (2006) Role of nitric oxide in Parkinson's disease. Pharmacol Ther 109: 33-41.